Clinical Trials Directory

Trials / Unknown

UnknownNCT05567614

Platelets Indices and Its Role to Predict Liver Fibrosis in Patients With Chronic Hepatitis B Infection

Status
Unknown
Phase
Study type
Observational
Enrollment
75 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Platelets indices and its role to predict liver Fibrosis in patients with chronic hepatitis B infection

Detailed description

Patients with chronic Hepatitis B infection will be collected and will do liver fibroscan to predict the degree of liver Fibrosis and correlate between the role of platelets count and degree of liver Fibrosis in patients with Chronic hepatitis B virus

Conditions

Interventions

TypeNameDescription
RADIATIONLiver FibroscanPatients with CHB virus will do liver fibroscan and correlat between platelets count and degree of liver fibrosis

Timeline

Start date
2022-10-20
Primary completion
2023-08-15
Completion
2023-12-15
First posted
2022-10-05
Last updated
2022-10-05

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05567614. Inclusion in this directory is not an endorsement.

Platelets Indices and Its Role to Predict Liver Fibrosis in Patients With Chronic Hepatitis B Infection (NCT05567614) · Clinical Trials Directory